Search - tctmd.com

Displaying 41 - 60 of 82

Sort: Relevancy | Date

Presentation CTO 2023

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

Presenter: Roxana Mehran

February 24, 2023

Presentation TCT 2022

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

Presenter: Seung Hun Lee

September 19, 2022

Presentation TCT 2022

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

Presenter: Mark Kheifets

September 17, 2022

Presentation THT 2022

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Presenter: Barry Greenberg

February 01, 2022

Session XI: Future Directions and Challenges in the MedTech Field - Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presentation TCT 2019

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

Presenter: Joydeep Sarkar

September 26, 2019

Presentation TCT 2018

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Presenter: Dominick J. Angiolillo, Elmir Omerovic, Duk-Woo Park

September 23, 2018

Presentation TCT 2017

Shockwave Therapy for Calcified Coronary Lesions: Device, Data, and Case Reviews

Presenter: Salvatore Brugaletta, Philippe Genereux, Jonathan M. Hill

November 01, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

Presentation Fellows 2017

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, David J. Cohen

April 07, 2017

Presentation Fellows 2017

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Gregg W. Stone

April 07, 2017

Presentation Fellows 2017

Antithrombin Therapy for the Interventionalist

Presenter: Manish A. Parikh, David J. Cohen

April 07, 2017

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

Duration of DAPT Therapy With Contemporary DES (Including BVS)

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Gustavo A Samaja

October 31, 2016

Presentation TVT 2016

Will General Anesthesia Be Needed for Valve Therapy?

Presenter: Douglas C Shook

June 18, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation Fellows 2016

The TAVR Revolution: The Future of Aortic Stenosis Therapy

Presenter: Mark Reisman, Susheel Kodali

April 17, 2016

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

Gene Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Gary L. Schaer

October 14, 2015

Presentation

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

Presenter: ES. Chung

June 22, 2015

Presentation TVT 2015

3M for Alternative Access TAVR? Early Experience and Next Steps

Presenter: Sandra Lauck, David A. Wood, Philippe Genereux

June 06, 2015

Advertisement

CTO and Higher Risk PCI in a HBR Patient: What Should I Be Doing With DAPT +/- Anticoagulation Therapy?

TCT 31: Clinical Impact of Genetics on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention Using Drug-Eluting Stent

TCT 19: Thrombin Generation and Endothelial Progenitor Cell Function in Patients with Acute Myocardial Infarction Treated with Prasugrel versus Ticagrelor

Results From First-In-Human Clinical Trial of RP-A501 (AAV9:LAMP2B) Gene Therapy Treatment for Danon Disease

Featured Technology: Real-World Evidence Generation Technology Using Artificial Intelligence and Deep Learning to Predict Disease Risk and Efficacy of Therapy (HOLMUSK)

The Asian Anti-Platelet Therapy Paradox: Genetic Factors, Dosing, Bleeding, and Stent Thrombosis Risk

Shockwave Therapy for Calcified Coronary Lesions: Device, Data, and Case Reviews

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antiplatelet Therapy for the Interventionalist

Antithrombin Therapy for the Interventionalist

Beyond Cells: Cardiac Gene Therapy In Perspective

Duration of DAPT Therapy With Contemporary DES (Including BVS)

Will General Anesthesia Be Needed for Valve Therapy?

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

The TAVR Revolution: The Future of Aortic Stenosis Therapy

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Gene Therapy for CHF

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

3M for Alternative Access TAVR? Early Experience and Next Steps

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content